Legislation Coming Up — Nov 25, 2015 3:07 a.m.
This bill has been added to the Senate’s floor schedule for the next legislative day.
Last Action: This bill passed in the House on June 9, 2015 and goes to the Senate next for consideration.
Jun 26, 2007
110th Congress, 2007–2009
This bill was introduced on June 27, 2007, in a previous session of Congress, but was not enacted.
Senator from Massachusetts
Read Text »
Last Updated: Nov 19, 2008
Length: 88 pages
A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes.
Biologics Price Competition and Innovation Act of 2007 - Amends the Public Health Service Act to allow a person to submit an application for licensure of a biological product based ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
Reported by Committee
A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.
This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 1695”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Search for similar bills.
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 1695 — 110th Congress: Biologics Price Competition and Innovation Act of 2007. Retrieved from https://www.govtrack.us/congress/bills/110/s1695
“S. 1695 — 110th Congress: Biologics Price Competition and Innovation Act of 2007.” www.GovTrack.us. 2007. November 28, 2015 <https://www.govtrack.us/congress/bills/110/s1695>
|title=S. 1695 (110th)
|accessdate=November 28, 2015
|author=110th Congress (2007)
|date=June 26, 2007
|quote=Biologics Price Competition and Innovation Act of 2007